Home | Business News | Browse by Publication | B | Biotech Business

OSTEOLOGIX GETS PATENT ALLOWANCE FOR OSTEOPOROSIS DRUG.

Publication: Biotech Business
Publication Date: 01-JUL-09
Format: Online
Delivery: Immediate Online Access

Article Excerpt
Osteologix, Inc. (OTCBB:OLGX), has received a Notice of Allowance from the U.S. Patent and Trademark Office for its U.S. Patent Application Number 11/269,289 titled "Water-Soluble Strontium Salts for Use in Treatment of Cartilage and/or Bone Conditions" reporting allowance of claims covering the treatment of osteoporosis and related bone conditions using NB S101 (strontium malonate), the company's lead osteoporosis drug candidate. The company expects the patent will issue in the...

Access Full Article, Compliments of Goliath



More articles from Biotech Business
ALEXION'S SOLIRIS PREVENTS REJECTION IN KIDNEY TRANSPLANTS.(Clinical r..., July 01, 2009
HPV STATUS PREDICTS SURVIVAL IN OROPHARYNGEAL CANCERS.(Clinical report..., July 01, 2009
SHORT-COURSE RADIOTHERAPY EFFECTIVE FOR BONE METASTASES., July 01, 2009

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.